Emeren Group Ltd (SOL)
NYSE: SOL · Real-Time Price · USD
1.850
0.00 (0.00%)
At close: Aug 26, 2025, 4:00 PM
1.870
+0.020 (1.08%)
After-hours: Aug 26, 2025, 7:58 PM EDT
Emeren Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 67.42 | 91.07 | 104.78 | 60.17 | 79.66 | 73.5 | Upgrade |
Other Revenue | 1.03 | 1 | 0.86 | 1.12 | - | - | Upgrade |
| 68.45 | 92.07 | 105.64 | 61.29 | 79.66 | 73.5 | Upgrade | |
Revenue Growth (YoY) | -33.92% | -12.85% | 72.36% | -23.06% | 8.38% | -38.29% | Upgrade |
Cost of Revenue | 48.15 | 67.95 | 80.63 | 45.96 | 48.24 | 56.82 | Upgrade |
Gross Profit | 20.29 | 24.12 | 25.01 | 15.34 | 31.42 | 16.69 | Upgrade |
Selling, General & Admin | 27.45 | 23.31 | 26.36 | 17.62 | 17.3 | 14.95 | Upgrade |
Other Operating Expenses | -3.95 | -3.41 | 0.44 | 0.18 | 0.84 | 9.04 | Upgrade |
Operating Expenses | 23.5 | 19.91 | 26.8 | 17.8 | 18.14 | 23.98 | Upgrade |
Operating Income | -3.2 | 4.22 | -1.79 | -2.46 | 13.28 | -7.3 | Upgrade |
Interest Expense | -2.21 | -1.99 | -2.21 | -3.17 | -5.15 | -6.21 | Upgrade |
Interest & Investment Income | 1.29 | 1.43 | 2.07 | 1.56 | 1.65 | 0.98 | Upgrade |
Currency Exchange Gain (Loss) | 10.16 | -8.52 | 5.89 | 1.61 | -1.76 | 0.77 | Upgrade |
EBT Excluding Unusual Items | 6.04 | -4.86 | 3.97 | -2.46 | 8.02 | -11.76 | Upgrade |
Gain (Loss) on Sale of Investments | -0 | -0 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -3.24 | -2.14 | -2.48 | -0.17 | -0.27 | 15.51 | Upgrade |
Asset Writedown | -27.33 | - | -1.69 | - | -0.36 | -1.43 | Upgrade |
Other Unusual Items | -6.39 | -2.58 | -2.7 | - | - | - | Upgrade |
Pretax Income | -30.93 | -9.59 | -2.9 | -2.63 | 7.39 | 2.32 | Upgrade |
Income Tax Expense | 1.32 | 2.02 | 2.53 | 1.92 | 0.77 | 0.16 | Upgrade |
Earnings From Continuing Operations | -32.25 | -11.61 | -5.43 | -4.55 | 6.61 | 2.16 | Upgrade |
Net Income to Company | -32.25 | -11.61 | -5.43 | -4.55 | 6.61 | 2.16 | Upgrade |
Minority Interest in Earnings | 28.3 | -0.87 | 2.25 | -0.12 | 0.25 | 0.62 | Upgrade |
Net Income | -3.95 | -12.48 | -3.19 | -4.67 | 6.86 | 2.78 | Upgrade |
Net Income to Common | -3.95 | -12.48 | -3.19 | -4.67 | 6.86 | 2.78 | Upgrade |
Net Income Growth | - | - | - | - | 146.95% | - | Upgrade |
Shares Outstanding (Basic) | 51 | 52 | 57 | 65 | 69 | 49 | Upgrade |
Shares Outstanding (Diluted) | 51 | 52 | 57 | 65 | 70 | 50 | Upgrade |
Shares Change (YoY) | -5.12% | -8.28% | -12.93% | -7.04% | 40.27% | 22.64% | Upgrade |
EPS (Basic) | -0.08 | -0.24 | -0.06 | -0.07 | 0.10 | 0.06 | Upgrade |
EPS (Diluted) | -0.08 | -0.24 | -0.10 | -0.10 | 0.10 | 0.06 | Upgrade |
EPS Growth | - | - | - | - | 76.20% | - | Upgrade |
Free Cash Flow | -8.72 | -20.04 | -34.24 | -75.63 | -17.72 | -18.28 | Upgrade |
Free Cash Flow Per Share | -0.17 | -0.39 | -0.61 | -1.17 | -0.25 | -0.37 | Upgrade |
Gross Margin | 29.65% | 26.20% | 23.68% | 25.02% | 39.45% | 22.70% | Upgrade |
Operating Margin | -4.68% | 4.58% | -1.69% | -4.02% | 16.67% | -9.93% | Upgrade |
Profit Margin | -5.77% | -13.55% | -3.02% | -7.62% | 8.61% | 3.78% | Upgrade |
Free Cash Flow Margin | -12.73% | -21.77% | -32.41% | -123.40% | -22.24% | -24.87% | Upgrade |
EBITDA | 4.96 | 11.13 | 6.04 | 4.36 | 20.08 | 0.04 | Upgrade |
EBITDA Margin | 7.25% | 12.09% | 5.72% | 7.11% | 25.20% | 0.06% | Upgrade |
D&A For EBITDA | 8.16 | 6.92 | 7.83 | 6.82 | 6.79 | 7.34 | Upgrade |
EBIT | -3.2 | 4.22 | -1.79 | -2.46 | 13.28 | -7.3 | Upgrade |
EBIT Margin | -4.68% | 4.58% | -1.69% | -4.02% | 16.67% | -9.93% | Upgrade |
Effective Tax Rate | - | - | - | - | 10.48% | 7.03% | Upgrade |
Revenue as Reported | 68.45 | 92.07 | 105.64 | 61.29 | 79.66 | 73.5 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.